XML 19 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Cash flows from operating activities:    
Net loss $ 7,294,489 $ 5,539,903
Adjustments to reconcile net loss to net cash (used in) by operating activities    
Depreciation expense 92,226 27,947
Amortization of patents 70,699 69,428
Common stock and options for compensation, consulting and vendor services 1,850,760 1,128,274
Equity loss (gain) on joint venture 795,827 2,445,489
Changes in operating assets and liabilities:    
Increase (Decrease) in accounts receivable 635,017 (207,248)
Increase in due from related party (1,727,210)
Decrease (Increase) in other receivable 48,515 (58,140)
Increase in inventories (509,462) (875,034)
Decrease (Increase) to advances on contracts 514,228 (450,407)
Increase in deferred cost (620,041)
Decrease to prepaid expenses and other current assets 12,675 192,601
(Increase) in other assets (2,670)
Increase in accounts payable 486,348 173,068
Decrease in accrued expenses and other payables (755,915) 220,038
Increase in deferred revenue 1,001,800
Net cash (used in) operating activities (5,398,581) (2,946,338)
Cash flows from investing activities:    
Purchases of intangible assets (15,615) (9,939)
Purchases of property and equipment (15,344) (67,581)
Consolidation of variable interest entity 39,165 (3,649,751)
Net cash provided by (used in) investing activities 8,206 (3,727,271)
Cash flows from financing activities:    
Net proceeds on private placement offering 2,225,000
Net proceeds on public offering 2,573,220
Capital contribution from noncontrolling interest 500,000
Net cash provided by investing activities 4,798,220 500,000
Net (decrease) in cash and cash equivalents (592,155) (6,173,609)
Cash and cash equivalents at beginning of year 4,194,384 10,367,993
Cash and cash equivalents at end of year 3,602,229 4,194,384
Supplemental disclosure of cash flow information:    
Net assets acquired from variable interest entity 16,346 566,775
Milestone Medical Inc. [Member]    
Adjustments to reconcile net loss to net cash (used in) by operating activities    
Equity loss (gain) on joint venture 2,019,211
Milestone Education LLC [Member]    
Adjustments to reconcile net loss to net cash (used in) by operating activities    
Equity loss (gain) on joint venture 7,846
Milestone China [Member]    
Adjustments to reconcile net loss to net cash (used in) by operating activities    
Equity loss (gain) on joint venture $ 795,827 $ 418,432